Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × INDUSTRY × Chlorhexidine × Clear all

Phase

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Paclitaxel 226 Carboplatin 226 Gemcitabine 208 Bevacizumab 194 Cisplatin 192 Docetaxel 191 pembrolizumab 186 Pemetrexed 135 Capecitabine 128 Fluorouracil 109 Cyclophosphamide 105 Oxaliplatin 102 Nivolumab 95 Dexamethasone 82 Leucovorin 78 Irinotecan 73 Rituximab 72 Trastuzumab 71 Injections 67 Cetuximab 66 Prednisone 61 Ipilimumab 59 Erlotinib Hydrochloride 58 Doxorubicin 58 atezolizumab 57 Temozolomide 57 Bortezomib 55 Radiotherapy 51 Fulvestrant 48 Drug Therapy 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06120140 2026-03-13

COCOON

Janssen Research & Development, LLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡